Pre-B cell acute lymphoblastic leukemia in the newborn.
Leukemia in the newborn is an infrequent disease that has not been well defined using modern laboratory techniques. We describe two infants, one at birth and one at four weeks, with acute lymphoblastic leukemia. The blasts from each patient were studied in great detail, using a battery of cytochemical and immunologic procedures in addition to ultrastructural studies. Immunologic cell marker studies, not previously reported in congenital leukemia, showed the lymphoblasts from each infant to be of the pre-B cell phenotype. Each infant relapsed, one after a 17-week clinical remission and the other after a 44-week remission. The former has died while the latter is in a second remission. The subtype of pre-B cell acute lymphoblastic leukemia (ALL) which in childhood appears to confer an unfavorable prognosis, may have the same significance in neonatal ALL.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000235:genetics / Q000276:immunology; D008214:Lymphocytes / Q000648:ultrastructure; D008297:Male; D008854:Microscopy, Electron; D010641:Phenotype; D011379:Prognosis; D011947:Receptors, Antigen, B-Cell / Q000276:immunology
D000970:Antineoplastic Agents; D011947:Receptors, Antigen, B-Cell